Type I IFN plays a crucial role in the pathogenesis of SLE [4, 6–10, 26], and the IFN-inducible gene signature may serve as a marker for more severe disease involving the kidneys, hematopoietic cells, and the central nervous system [26]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.